Cardio-renoprotective effects of SGLT2 inhibitors-the role of anaemia correction

Nephrol Dial Transplant. 2024 May 31;39(6):904-906. doi: 10.1093/ndt/gfae019.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anemia* / drug therapy
  • Anemia* / etiology
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors